Frozen Autologous Blood Dose Tray for Skin Injury Healing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for skin injuries lack an effective method to enhance the healing process by efficiently delivering concentrated growth factors directly to the injury site while providing additional therapeutic benefits.
Innovation Solution
A method involving the freezing of autologous blood components, such as platelet-rich plasma, in individual doses using a tray assembly, which are then applied frozen to the skin injury, combining biologic and cold therapy to stimulate healing and reduce pain and inflammation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If autologous blood components are applied to skin injuries to deliver growth factors, then healing is enhanced, but repeated blood withdrawals are required increasing treatment complexity and cost
Solution Approach 1:
The patent applies preliminary action by harvesting and freezing autologous blood components in advance into individual doses. These pre-prepared frozen doses can be stored and applied later without requiring additional blood withdrawals, thus enhancing healing reliability while reducing treatment complexity and the need for repeated invasive procedures
Solution Approach 2:
The patent creates copies of the therapeutic blood components by freezing multiple individual doses in advance. Each frozen dose is a stable copy that can be stored and applied as needed, eliminating the need for repeated blood draws and reducing treatment complexity while maintaining therapeutic effectiveness
2Ease of operation
If frozen autologous blood components are used for treatment, then self-administration is enabled, but handling and storage requirements increase
Solution Approach 1:
The patent segments the blood components into individual single-use frozen doses, each contained in separate compartments. This segmentation enables easy self-administration by the patient while the compact individual portions simplify storage requirements compared to storing large volumes of fresh blood
Solution Approach 2:
The patent changes the physical state of the blood components from liquid to frozen, which extends storage time and enables self-administration. The frozen state allows the treatment to be stored in standard freezers and applied by patients at home, balancing the improved ease of operation with manageable storage requirements
3Adaptability or versatility
If multiple individual doses are prepared, then treatment flexibility increases, but manufacturing and storage complexity increase
Solution Approach 1:
The patent creates a universal frozen dose system where each individual dose can be used for multiple different skin injuries and treatment scenarios. The standardized frozen doses provide treatment flexibility across various applications while using a single manufacturing process, reducing overall manufacturing complexity despite producing multiple doses
Solution Approach 2:
By preparing multiple individual doses in advance through a single blood draw and freezing process, the system achieves treatment flexibility for multiple future injuries while consolidating the manufacturing effort into one initial procedure, thereby reducing overall manufacturing complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances the healing process by delivering high levels of growth factors directly to the injury site, promoting tissue growth and reducing the need for repeated blood withdrawals, lowering treatment costs, and allowing for self-administration of treatments.
Implementation Method 1
freezing an autologous blood component in a plurality of individual doses
Implementation Method 2
combining biologic and cold therapy to stimulate healing and reduce pain and inflammation
Data Source
AI summary
This disclosure describes a combined autologous biologic and cold therapy treatment for treating various skin injuries. The treatment may include applying autologous blood components, including but not limited to platelet rich plasma, to a skin injury in a manner that influences the healing process. A tray assembly for freezing autologous blood components includes a tray body and a plurality of compartments formed in the tray body. Each of the plurality of compartments is configured to receive an individual dose of an autologous blood component.